<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e> is generally a benign disorder </plain></SENT>
<SENT sid="1" pm="."><plain>It has been reported to occur in <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo>, particularly after the initiation of <z:chebi fb="0" ids="18332">L-thyroxine</z:chebi> replacement therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Previous case reports have involved children primarily in the peripubertal age range (approximately 8 to 13 years) </plain></SENT>
<SENT sid="3" pm="."><plain>We report here the development of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> in an infant who required treatment with <z:chebi fb="0" ids="18332">L-thyroxine</z:chebi> for transient neonatal <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> as a result of maternal thyroid-stimulating hormone receptor-blocking antibodies </plain></SENT>
</text></document>